MENU
IBO
Stock ticker: ASE
PRICE
CHANGE
CAPITALIZATION
Impact BioMedical (IBO) Ownership - Who owns Impact BioMedical?
Impact BioMedical Inc focuses on the advancement of drug discovery and prevention, inhibition, and treatment of neurological, oncological, and immune-related diseases... Show more
Profile
Industry
N/A
Address
275 Wiregrass Parkway
Phone
+1 585 325-3610
Employees
N/A
Web
https://www.impactbiomedinc.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
6.02M
P/E Ratio
8.10
Total Cash
2.67M
Projected Growth
N/A
Total Debt
8.01M
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
0.22
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
IBO
Capitalization
6.02M
P/E Ratio
8.10
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
2.67M
Total Cash/Share
0.22
Total Debt
8.01M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
31.3M
P/B Ratio
1.59
Cash Flow
N/A
Earnings
0.1
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
11K
Current Ratio
2.79
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
3.14M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
2.54
Shares Held By Institutions
168K
Shares Outstanding - Current
12.1M
Total Liabilities
12.3M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-65.517
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
275 Wiregrass Parkway
Phone
+1 585 325-3610
Employees
N/A
Web
https://www.impactbiomedinc.com